Hussman Strategic Advisors, Inc. Gilead Sciences, Inc. Put Options Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GILD
# of Institutions
2,381Shares Held
1.02BCall Options Held
12.6MPut Options Held
9.18M-
Black Rock Inc. New York, NY121MShares$15.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.9 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.4 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.66 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.77 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $157B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...